Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method

a technology of endothelin and determination method, which is applied in the field of determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method. it can solve the problems of possible further processing and stability, and nothing has been disclosed to da

Active Publication Date: 2012-02-28
BRAHMS GMBH
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0015]Such a method should be valid and capable of routine use and should be capable of providing reliable values for the physiological production of ET (ET-1) and / or its precursors in various pathological conditions, in particular in sepsis or other pathological conditions in which increased values for endothelin play a role.

Problems solved by technology

During such processing, further peptides form in primarily stoichiometric amounts in addition to big endothelin (and therefrom endothelin), which further peptides, however, have to date not been the subject of scientific investigations and about whose possible further processing and stability nothing has been disclosed to date.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
  • Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method
  • Method for the determination of the formation of endothelins for medical diagnostic purposes, and antibodies and kits for carrying out such a method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0029]The method according to the invention relates in its most general aspect to the determination of a relatively long-lived peptide fragment of proendothelin-1 which does not contain the amino acid sequences of endothelin-1 or its precursor big endothelin, in whole blood, plasma or serum samples, i.e. in the circulation of patients, for the indirect determination of the formation of endothelins, in particular of endothelin-1, in serious diseases. According to a preferred embodiment, the peptide fragment determined is a C-terminal fragment to which two antibodies bind which bind to peptides having amino acid sequences which correspond to the positions 168-181 and 200-212 of preproendothelin-1.

[0030]For the practical implementation of the invention, noncompetitive sandwich assays, for example of the type as used for the more far-reaching detailed investigations and described more exactly below, are particularly preferably provided.

[0031]Compared with competitive immunoassays, nonco...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
residence timeaaaaaaaaaa
massaaaaaaaaaa
massaaaaaaaaaa
Login to view more

Abstract

The invention relates to an in vitro method for detecting the formation of endothelins during serious illnesses, especially cardiovascular diseases, inflammations, sepsis and cancer, in whole blood, plasma or serum of a human patient for medical diagnosis. Using this method, relatively long-lasting peptide fragments, especially a C-terminal peptide fragment, of the processed primary prepro- or proendothelins that contain neither the actual biologically active endothelin nor its direct precursor, big endothelin, can be detected.

Description

CROSS REFERENCE TO RELATED APPLICATIONS[0001]This application is a U.S. national stage filing under 35 U.S.C. §371 U.S. of PCT Application Ser. No. PCT / EP2005 / 001359 having an international filing date of Feb. 10, 2005, published in German under Publication No. WO 2005 / 078456 A1 on Aug. 25, 2005, which claims priority from European Application Ser. No. EP 04003295.5, filed Feb. 13, 2004; the disclosures of these applications are hereby incorporated by reference in their entirety.FIELD OF THE INVENTION[0002]The invention relates to methods for the determination of the formation of endothelins in serious diseases by determining peptide fragments of the corresponding proendothelin, in particular a relatively long-lived C-terminal partial peptide of preproendothelin-1, in the circulation (whole blood, plasma or serum) for medical diagnostic purposes, in particular in sepsis diagnosis, in cardiac diagnosis and, for example, also in cancer diagnosis and / or generally in the diagnosis of th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(United States)
IPC IPC(8): G01N33/00G01N33/574G01N33/68G01N33/74
CPCG01N33/57488G01N33/6893G01N33/74C07K16/00G01N2333/5754Y10S435/975
Inventor BERGMANN, ANDREASSTRUCK, JOACHIM
Owner BRAHMS GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products